Brief: Theravance Biopharma Q3 Operating Income USD -6.455 Million
10/11/2025 21:05
Nov 10 (Reuters) - Theravance Biopharma Q3 revenue USD 19.99 million vs. IBES estimate USD 19.3 million. Q3 net income USD 3.615 million Q3 adjusted net income USD 2.26 million vs. IBES estimate USD -6.76 million Q3 EPS USD 0.07
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions